A citation-based method for searching scientific literature

Luis Velázquez-Pérez, Julio C Rodríguez-Diaz, Roberto Rodríguez-Labrada, Jacqueline Medrano-Montero, Annety B Aguilera Cruz, Lorenzo Reynaldo-Cejas, Mariela Góngora-Marrero, Annelié Estupiñán-Rodríguez, Yaimeé Vázquez-Mojena, Reidenis Torres-Vega. Mov Disord 2019
Times Cited: 9







List of co-cited articles
69 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effects of Physical Rehabilitation in Patients with Spinocerebellar Ataxia Type 7.
Karla Tercero-Pérez, Hernán Cortés, Yessica Torres-Ramos, Roberto Rodríguez-Labrada, César M Cerecedo-Zapata, Oscar Hernández-Hernández, Nelson Pérez-González, Rigoberto González-Piña, Norberto Leyva-García, Bulmaro Cisneros,[...]. Cerebellum 2019
16
66

The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.
Luis Ruano, Claudia Melo, M Carolina Silva, Paula Coutinho. Neuroepidemiology 2014
286
55

Spinocerebellar ataxia.
Thomas Klockgether, Caterina Mariotti, Henry L Paulson. Nat Rev Dis Primers 2019
164
55

Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
990
44

Cycling regimen induces spinal circuitry plasticity and improves leg muscle coordination in individuals with spinocerebellar ataxia.
Ya-Ju Chang, Ching-Chieh Chou, Wan-Ting Huang, Chin-Song Lu, Alice M Wong, Miao-Ju Hsu. Arch Phys Med Rehabil 2015
23
44

Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases.
Ichiro Miyai, Mizuki Ito, Noriaki Hattori, Masahito Mihara, Megumi Hatakenaka, Hajime Yagura, Gen Sobue, Masatoyo Nishizawa. Neurorehabil Neural Repair 2012
106
44

Intensive coordinative training improves motor performance in degenerative cerebellar disease.
W Ilg, M Synofzik, D Brötz, S Burkard, M A Giese, L Schöls. Neurology 2009
153
44

Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7.
Pavitra S Ramachandran, Ryan L Boudreau, Kellie A Schaefer, Albert R La Spada, Beverly L Davidson. Mol Ther 2014
37
33

An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron.
Yu Miyazaki, Xiaofei Du, Shin-Ichi Muramatsu, Christopher M Gomez. Sci Transl Med 2016
37
33

Neurorehabilitation therapy in spinocerebellar ataxia type 2: A 24-week, rater-blinded, randomized, controlled trial.
Julio Cesar Rodríguez-Díaz, Luis Velázquez-Pérez, Roberto Rodríguez Labrada, Raúl Aguilera Rodríguez, Dalina Laffita Pérez, Nalia Canales Ochoa, Jacqueline Medrano Montero, Annelié Estupiñán Rodríguez, Marcos Osorio Borjas, Mariela Góngora Marrero,[...]. Mov Disord 2018
20
33

Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
Daniel R Scoles, Pratap Meera, Matthew D Schneider, Sharan Paul, Warunee Dansithong, Karla P Figueroa, Gene Hung, Frank Rigo, C Frank Bennett, Thomas S Otis,[...]. Nature 2017
164
33

Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7.
Chenchen Niu, Thazah P Prakash, Aneeza Kim, John L Quach, Laryssa A Huryn, Yuechen Yang, Edith Lopez, Ali Jazayeri, Gene Hung, Bryce L Sopher,[...]. Sci Transl Med 2018
42
33

Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models.
Lauren R Moore, Gautam Rajpal, Ian T Dillingham, Maya Qutob, Kate G Blumenstein, Danielle Gattis, Gene Hung, Holly B Kordasiewicz, Henry L Paulson, Hayley S McLoughlin. Mol Ther Nucleic Acids 2017
73
33

Spinocerebellar ataxia: an update.
Roisin Sullivan, Wai Yan Yau, Emer O'Connor, Henry Houlden. J Neurol 2019
69
33

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
T A Zesiewicz, P E Greenstein, K L Sullivan, L Wecker, A Miller, I Jahan, R Chen, S L Perlman. Neurology 2012
71
33

CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
Shuming Ouyang, Yingjun Xie, Zeyu Xiong, Yi Yang, Yexing Xian, Zhanhui Ou, Bing Song, Yuchang Chen, Yuhuan Xie, Haoxian Li,[...]. Stem Cells Dev 2018
34
33

Spinocerebellar ataxias: prospects and challenges for therapy development.
Tetsuo Ashizawa, Gülin Öz, Henry L Paulson. Nat Rev Neurol 2018
86
33

A randomized controlled pilot trial of game-based training in individuals with spinocerebellar ataxia type 3.
Ray-Yau Wang, Fang-Yi Huang, Bing-Wen Soong, Shih-Fong Huang, Yea-Ru Yang. Sci Rep 2018
16
33

Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice.
Clévio Nóbrega, Isabel Nascimento-Ferreira, Isabel Onofre, David Albuquerque, Hirokazu Hirai, Nicole Déglon, Luís Pereira de Almeida. PLoS One 2013
84
22

Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial.
Alberto Benussi, Valentina Dell'Era, Valentina Cantoni, Elisa Bonetta, Roberto Grasso, Rosa Manenti, Maria Cotelli, Alessandro Padovani, Barbara Borroni. Neurology 2018
40
22

Targeting potassium channels to treat cerebellar ataxia.
David D Bushart, Ravi Chopra, Vikrant Singh, Geoffrey G Murphy, Heike Wulff, Vikram G Shakkottai. Ann Clin Transl Neurol 2018
33
22

Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
Silvia Romano, Giulia Coarelli, Christian Marcotulli, Luca Leonardi, Francesca Piccolo, Maria Spadaro, Marina Frontali, Michela Ferraldeschi, Maria Chiara Vulpiani, Federica Ponzelli,[...]. Lancet Neurol 2015
108
22

Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles.
Jillian Friedrich, Holly B Kordasiewicz, Brennon O'Callaghan, Hillary P Handler, Carmen Wagener, Lisa Duvick, Eric E Swayze, Orion Rainwater, Bente Hofstra, Michael Benneyworth,[...]. JCI Insight 2018
49
22

Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice.
Lodewijk J A Toonen, Frank Rigo, Haico van Attikum, Willeke M C van Roon-Mom. Mol Ther Nucleic Acids 2017
59
22

Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating Scale and body stabilometry.
I Yabe, H Sasaki, I Yamashita, A Takei, K Tashiro. Acta Neurol Scand 2001
46
22

Safety and efficacy of valproic acid treatment in SCA3/MJD patients.
Li-Fang Lei, Guo-Ping Yang, Jun-Ling Wang, De-Maw Chuang, Wei-Hong Song, Bei-Sha Tang, Hong Jiang. Parkinsonism Relat Disord 2016
35
22

Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.
Tetsuo Ashizawa, Karla P Figueroa, Susan L Perlman, Christopher M Gomez, George R Wilmot, Jeremy D Schmahmann, Sarah H Ying, Theresa A Zesiewicz, Henry L Paulson, Vikram G Shakkottai,[...]. Orphanet J Rare Dis 2013
76
22

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.
V Campuzano, L Montermini, M D Moltò, L Pianese, M Cossée, F Cavalcanti, E Monros, F Rodius, F Duclos, A Monticelli,[...]. Science 1996
22

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Heike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, Paola Giunti, Arron Cook, Robyn Labrum, Michael H Parkinson, Alexandra Durr, Alexis Brice, Perrine Charles,[...]. Lancet Neurol 2015
127
22

Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
T Schmitz-Hübsch, M Coudert, P Bauer, P Giunti, C Globas, L Baliko, A Filla, C Mariotti, M Rakowicz, P Charles,[...]. Neurology 2008
174
22

Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats.
G Imbert, F Saudou, G Yvert, D Devys, Y Trottier, J M Garnier, C Weber, J L Mandel, G Cancel, N Abbas,[...]. Nat Genet 1996
716
22

A home balance exercise program improves walking in people with cerebellar ataxia.
Jennifer L Keller, Amy J Bastian. Neurorehabil Neural Repair 2014
39
22

Rehabilitation for Individuals With Genetic Degenerative Ataxia: A Systematic Review.
Sarah C Milne, Louise A Corben, Nellie Georgiou-Karistianis, Martin B Delatycki, Eppie M Yiu. Neurorehabil Neural Repair 2017
29
22

Treatment Options in Degenerative Cerebellar Ataxia: A Systematic Review.
Harini Sarva, Vicki Lynn Shanker. Mov Disord Clin Pract 2014
18
22


Spinocerebellar ataxia 2 (SCA2).
Isabel Lastres-Becker, Udo Rüb, Georg Auburger. Cerebellum 2008
142
22

Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.
Lindsay A Becker, Brenda Huang, Gregor Bieri, Rosanna Ma, David A Knowles, Paymaan Jafar-Nejad, James Messing, Hong Joo Kim, Armand Soriano, Georg Auburger,[...]. Nature 2017
242
22

ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
Pan P Li, Xin Sun, Guangbin Xia, Nicolas Arbez, Sharan Paul, Shanshan Zhu, H Benjamin Peng, Christopher A Ross, Arnulf H Koeppen, Russell L Margolis,[...]. Ann Neurol 2016
34
22

Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice.
Edgardo Rodríguez-Lebrón, Maria do Carmo Costa, Katiuska Luna-Cancalon, Therese M Peron, Svetlana Fischer, Ryan L Boudreau, Beverly L Davidson, Henry L Paulson. Mol Ther 2013
78
22

Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide.
Eleni Kourkouta, Rudie Weij, Anchel González-Barriga, Melissa Mulder, Ruurd Verheul, Sieto Bosgra, Bas Groenendaal, Jukka Puoliväli, Jussi Toivanen, Judith C T van Deutekom,[...]. Mol Ther Nucleic Acids 2019
20
22


Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease.
Maria do Carmo Costa, Katiuska Luna-Cancalon, Svetlana Fischer, Naila S Ashraf, Michelle Ouyang, Rahil M Dharia, Lucas Martin-Fishman, Yemen Yang, Vikram G Shakkottai, Beverly L Davidson,[...]. Mol Ther 2013
72
22


Diseases of unstable repeat expansion: mechanisms and common principles.
Jennifer R Gatchel, Huda Y Zoghbi. Nat Rev Genet 2005
560
22

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion.
Anna Niewiadomska-Cimicka, Antoine Hache, Yvon Trottier. Front Neurosci 2020
6
33

Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.
Anna Niewiadomska-Cimicka, Yvon Trottier. Neurotherapeutics 2019
16
22

Oligonucleotide-based strategies to combat polyglutamine diseases.
Agnieszka Fiszer, Wlodzimierz J Krzyzosiak. Nucleic Acids Res 2014
43
22

New RNAi strategy for selective suppression of a mutant allele in polyglutamine disease.
Takayuki Kubodera, Takanori Yokota, Kinya Ishikawa, Hidehiro Mizusawa. Oligonucleotides 2005
25
22

Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.
Vitor Carmona, Janete Cunha-Santos, Isabel Onofre, Ana Teresa Simões, Udaya Vijayakumar, Beverly L Davidson, Luís Pereira de Almeida. Mol Ther 2017
30
22

Knockdown and replacement therapy mediated by artificial mirtrons in spinocerebellar ataxia 7.
Helen J Curtis, Yiqi Seow, Matthew J A Wood, Miguel A Varela. Nucleic Acids Res 2017
10
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.